Management of COVID-19: current status and future prospects.
COVID-19
Management
SARS-CoV-2
Social impact
Treatments
Vaccinations
Journal
Microbes and infection
ISSN: 1769-714X
Titre abrégé: Microbes Infect
Pays: France
ID NLM: 100883508
Informations de publication
Date de publication:
Historique:
received:
24
02
2021
revised:
03
04
2021
accepted:
04
04
2021
pubmed:
20
4
2021
medline:
24
7
2021
entrez:
19
4
2021
Statut:
ppublish
Résumé
COVID-19, a highly transmissible pandemic disease, is affecting millions of lives around the world. Severely infected patients show acute respiratory distress symptoms. Sustainable management strategies are required to save lives of the infected people and further preventing spread of the virus. Diagnosis, treatment, and vaccination development initiatives are already exhibited from the scientific community to fight against this virus. In this review, we primarily discuss the management strategies including prevention of spread, prophylaxis, vaccinations, and treatment for COVID-19. Further, analysis of vaccine development status and performance are also briefly discussed. Global socioeconomic impact of COVID-19 is also analyzed as part of this review.
Identifiants
pubmed: 33872807
pii: S1286-4579(21)00054-X
doi: 10.1016/j.micinf.2021.104832
pmc: PMC8052512
pii:
doi:
Substances chimiques
Antiviral Agents
0
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
104832Subventions
Organisme : National Science Foundation
ID : 2027890
Organisme : National Science Foundation
ID : 1942487
Informations de copyright
Copyright © 2021 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest U. Demirci is a founder of and has an equity interest in: (i) DxNow Inc., a company that is developing microfluidic IVF tools and imaging technologies for point-of-care diagnostic solutions, (ii) Koek Biotech, a company that is developing microfluidic technologies for clinical solutions, (iii) Levitas Inc., a company focusing on developing microfluidic products for sorting rare cells from liquid biopsy in cancer and other diseases, and (iv) Hillel Inc., a company bringing microfluidic cell phone tools to home settings, (v) Mercury Biosciences, a company focused on extracellular vesicles. UD's interests were viewed and managed in accordance with the conflict of interest policies. All other authors declare no financial conflict of interests. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Références
J Med Device. 2018 Dec;12(4):0408021-4080211
pubmed: 30662580
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
JAMA. 2020 May 12;323(18):1824-1836
pubmed: 32282022
Science. 2020 Aug 21;369(6506):1010-1014
pubmed: 32540901
Nature. 2020 Oct;586(7828):186-189
pubmed: 33024333
Lancet Psychiatry. 2020 Apr;7(4):e21
pubmed: 32199510
N Engl J Med. 2021 Apr 22;384(16):1491-1502
pubmed: 33631065
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Infect Genet Evol. 2020 Sep;83:104351
pubmed: 32387564
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
Am J Trop Med Hyg. 2020 Oct;103(4):1608-1613
pubmed: 32815514
Cell Death Differ. 2021 Feb;28(2):626-639
pubmed: 33479399
Curr Trop Med Rep. 2020;7(2):61-64
pubmed: 32219057
J Behav Addict. 2020 Apr 29;9(2):184-186
pubmed: 32352927
Occup Med (Lond). 2007 Dec;57(8):552-6
pubmed: 18045976
Lancet. 2020 May 30;395(10238):1695-1704
pubmed: 32401715
MAbs. 2020 Jan-Dec;12(1):1854149
pubmed: 33319649
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Nature. 2020 Jul;583(7815):290-295
pubmed: 32422645
Nature. 2021 Apr;592(7852):15-17
pubmed: 33762708
Science. 2020 May 8;368(6491):551
pubmed: 32381692
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
JAMA. 2020 Aug 4;324(5):524
pubmed: 32530454
Vaccine. 2017 Jun 27;35(30):3780-3788
pubmed: 28579232
J Travel Med. 2020 Aug 20;27(5):
pubmed: 32502274
BMJ. 2020 Dec 30;371:m4968
pubmed: 33380513
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
EClinicalMedicine. 2021 Jan;31:100689
pubmed: 33392485
JAMA. 2021 Feb 9;325(6):532-533
pubmed: 33372955
Lancet Psychiatry. 2020 Jun;7(6):468-471
pubmed: 32330430
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1922-1924
pubmed: 33332292
Int J Surg. 2020 Jun;78:185-193
pubmed: 32305533
Br J Ophthalmol. 2021 Mar;105(3):306-310
pubmed: 32532764
Antib Ther. 2020 Nov 24;3(4):246-256
pubmed: 33912795
Science. 2020 Jul 3;369(6499):77-81
pubmed: 32376603
RSC Adv. 2019;9(15):8159-8168
pubmed: 31777654
Emerg Microbes Infect. 2020 Dec;9(1):542-544
pubmed: 32148172
Nature. 2020 Nov 11;:
pubmed: 33177689
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
Expert Rev Anti Infect Ther. 2021 Aug;19(8):1029-1037
pubmed: 33372567
Crit Rev Biotechnol. 2020 Aug;40(5):623-638
pubmed: 32308063
Diagnostics (Basel). 2020 Jan 14;10(1):
pubmed: 31947549
Sensors (Basel). 2021 Mar 05;21(5):
pubmed: 33807789
Travel Med Infect Dis. 2020 Mar - Apr;34:101631
pubmed: 32184129
BMJ. 2020 Mar 26;368:m1256
pubmed: 32217555
Int J Ment Health Nurs. 2020 Aug;29(4):549-552
pubmed: 32314526
Transfusion. 2020 Nov;60(11):2748-2752
pubmed: 32856742
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165878
pubmed: 32544429
JAMA. 2020 Jul 14;324(2):131-132
pubmed: 32539093
Science. 2020 Aug 21;369(6506):1014-1018
pubmed: 32540904
Nat Rev Drug Discov. 2020 May;19(5):305-306
pubmed: 32273591
Sci Total Environ. 2020 Aug 1;728:138861
pubmed: 32344226
Sci Transl Med. 2020 Apr 29;12(541):
pubmed: 32253226
Nature. 2020 Apr 29;:
pubmed: 32350436
Expert Rev Vaccines. 2012 Dec;11(12):1405-13
pubmed: 23252385
Nature. 2020 Aug;584(7821):334-335
pubmed: 32782400
Pathogens. 2020 Apr 26;9(5):
pubmed: 32357545
Clin Microbiol Infect. 2004 Jul;10(7):676-8
pubmed: 15214887
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6532-6539
pubmed: 27550352
Proc Natl Acad Sci U S A. 2021 Jan 26;118(4):
pubmed: 33431650
J Antibiot (Tokyo). 2020 Sep;73(9):593-602
pubmed: 32533071
Lancet Infect Dis. 2020 Apr;20(4):398-400
pubmed: 32113510
J Korean Med Sci. 2020 Apr 13;35(14):e149
pubmed: 32281317
Elife. 2020 Apr 02;9:
pubmed: 32228860
SN Compr Clin Med. 2020;2(8):1041-1044
pubmed: 32838170
N Engl J Med. 2021 Jan 21;384(3):238-251
pubmed: 33332778
Front Psychol. 2020 Oct 02;11:577684
pubmed: 33132986
Lancet. 2020 Jun 13;395(10240):1845-1854
pubmed: 32450106
Nat Nanotechnol. 2020 Aug;15(8):646-655
pubmed: 32669664
Nature. 2020 Apr;580(7805):576-577
pubmed: 32346146
Travel Med Infect Dis. 2020 Jul - Aug;36:101633
pubmed: 32205270
MMWR Morb Mortal Wkly Rep. 2021 Mar 05;70(9):329-332
pubmed: 33661860
Nat Microbiol. 2021 Jan;6(1):11-18
pubmed: 33273742
Proc Natl Acad Sci U S A. 2020 Dec 22;117(51):32293-32301
pubmed: 33273115
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):337-339
pubmed: 32305024
Nat Commun. 2020 May 20;11(1):2601
pubmed: 32433465
Arch Pathol Lab Med. 2020 Nov 1;144(11):1335-1343
pubmed: 32886758
J Med Virol. 2020 Oct;92(10):1890-1901
pubmed: 32293713
Antib Ther. 2020 Dec 28;3(4):285-299
pubmed: 33912797
PLoS One. 2020 Dec 18;15(12):e0244271
pubmed: 33338082
Sci Adv. 2020 Sep 2;6(36):
pubmed: 32917603
Nat Hum Behav. 2020 May;4(5):451-459
pubmed: 32377018
Nature. 2021 Mar 25;:
pubmed: 33767467
ACS Pharmacol Transl Sci. 2020 Sep 18;3(5):844-858
pubmed: 33062951
Nat Biotechnol. 2020 Nov 25;:
pubmed: 33239758
Iran J Med Sci. 2020 Mar;45(2):81-82
pubmed: 32210483
Sci Rep. 2020 Jul 17;10(1):11906
pubmed: 32681135
Pharmacol Res. 2020 Jul;157:104859
pubmed: 32360480
Comput Struct Biotechnol J. 2020 Dec 28;19:467-476
pubmed: 33505639
Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(7):449-463
pubmed: 28769016
J Occup Environ Hyg. 2014;11(8):509-18
pubmed: 24467190
Nature. 2020 Jan;577(7792):605-607
pubmed: 31992880
EClinicalMedicine. 2020 Apr 11;21:100348
pubmed: 32292900
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
BMJ. 2020 Dec 30;371:m4964
pubmed: 33380407
N Engl J Med. 2021 Feb 18;384(7):619-629
pubmed: 33232588
Pathogens. 2020 Sep 08;9(9):
pubmed: 32911671
Obesity (Silver Spring). 2020 Jun;28(6):1008-1009
pubmed: 32227671
N Engl J Med. 2020 Nov 19;383(21):2041-2052
pubmed: 32706953
J Med Virol. 2020 Jul;92(7):833-840
pubmed: 32243607
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Emerg Microbes Infect. 2020 Dec;9(1):386-389
pubmed: 32065057
Antimicrob Agents Chemother. 2020 May 21;64(6):
pubmed: 32312781
Sens Actuators B Chem. 2019 Mar 1;282:225-231
pubmed: 30828133
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
World J Pediatr. 2020 Jun;16(3):223-231
pubmed: 32034659
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Nat Commun. 2021 Jan 14;12(1):372
pubmed: 33446655
Immunity. 2020 Apr 14;52(4):583-589
pubmed: 32259480
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Expert Rev Mol Diagn. 2021 Mar;21(3):269-288
pubmed: 33621145